Status | Study |
Not yet recruiting |
Study Name: Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection Condition: HTLV-I Infections Tropical Spastic Paraparesis Date: 2015-11-16 Interventions: Drug: "Raltegravir" and "Zidovudine" Through measure of pro-viral load and clinical |
Recruiting |
Study Name: Raltegravir for HAM/TSP Condition: HTLV-I Infection Date: 2013-05-21 Interventions: Drug: Raltegravir |
Enrolling by invitation |
Study Name: Urological Physical Therapy in HTLV-1 With Urinary Symptoms Condition: Tropical Spastic Paraparesis HTLV-1 Date: 2012-07-25 Interventions: Procedure: Urological physical therapy Individual patient attending with one hour duration beginning wit |
Completed |
Study Name: Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases Condition: HTLV-1 Tropical Spastic Paraparesis Date: 2011-11-11 Interventions: Drug: Pentoxifylline Pentoxify |
Completed |
Study Name: Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) Condition: HTLV-I-Associated Myelopathy Date: 2011-04-25 Interventions: Drug: Tamibarotene Oral administration of tamibarotene 2 mg daily over a period of 12 weeks, then 4mg da |
Completed |
Study Name: Effects of Therapeutic Music Combined With Loaded Sit-to-Stand Resistance Exercise for Children With Spastic Diplegia Condition: Cerebral Palsy Paraparesis, Spastic Date: 2010-08-09 Interventions: Behavioral: Loaded sit-to-stand exercise |
Completed |
Study Name: Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) Condition: HTLV I Associated Myelopathy Date: 2008-10-15 Interventions: Drug: ciclosporin Ciclosporin 2.5 - 5mg/kg/day in two equally divided doses. dose adjusted according to |
Completed |
Study Name: Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM) Condition: Paraparesis Spastic Tropical Date: 2008-05-19 Interventions: Drug: Valproic acid 15 mg/kg/d |
Completed |
Study Name: Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS) Condition: Amyotrophic Lateral Sclerosis Lou Gehrig's Disease Primary Date: 2008-05-09 Interventions: Other: No intervention Sample collection |
Recruiting |
Study Name: Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Condition: HTLV-1 Date: 2006-07-12 Interventions: Drug: Hu MiK-Beta-1 |